Insider Trading November 16, 2026 08:16 PM

Expensify Director Offloads $660,596 in Shares Across Two-Day Sale

Steven J. McLaughlin sold 360,214 Class A shares on November 12 and 13, 2026, as the stock trades below recent highs.

By Ajmal Hussain
Share
Twitter Reddit Facebook LinkedIn
EXFY

Steven J. McLaughlin, a director and 10% owner of Expensify, Inc. (NASDAQ:EXFY), sold 360,214 Class A Common Stock shares for approximately $660,596 across two transactions on November 12 and November 13, 2026. The shares were sold at weighted average prices ranging from $1.826 to $1.838. The sale comes after the stock gained over 50% in the past six months, though shares have declined recently to $1.72. According to InvestingPro analysis, Expensify appears undervalued at current levels, with a Fair Value of $2.49. The company’s $170 million market cap reflects ongoing volatility, as highlighted in InvestingPro Tips. Following these transactions, Mr. McLaughlin beneficially owns 11,285,631 shares indirectly through the Steven J. McLaughlin Revocable Trust, for which he serves as the sole trustee. He also indirectly holds 1,783,610 shares through EXP 2020 SPV LP, where SF Roofdeck GP LLC acts as the general partner and is wholly owned by the Trust. Mr. McLaughlin disclaims beneficial ownership of these securities except to the extent of his pecuniary interest. In other recent news, Expensify reported financial results for the third quarter of 2026, revealing a wider-than-expected loss. The company posted a loss of 4 cents per share, contrary to analysts’ projections of a 2-cent profit. Revenue for the quarter was $33 million, falling short of the anticipated $33.73 million.

Expensify Director Offloads $660,596 in Shares Across Two-Day Sale
EXFY
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Director and 10% owner Steven J. McLaughlin sold 360,214 Class A shares for about $660,596 on November 12-13, 2026, at weighted average prices between $1.826 and $1.838.
  • The sale follows a 50% stock gain over six months, though shares have recently pulled back to $1.72, with InvestingPro flagging EXFY as undervalued versus a $2.49 Fair Value.
  • Expensify’s Q3 2026 results missed forecasts, with a 4-cent loss per share versus a 2-cent profit expected and revenue of $33 million below the $33.73 million consensus.

Expensify, Inc. (NASDAQ:EXFY) director and 10% owner Steven J. McLaughlin sold a total of 360,214 Class A Common Stock shares for approximately $660,596 across two transactions on November 12 and November 13, 2026. The shares were sold at weighted average prices ranging from $1.826 to $1.838. The sale comes after the stock gained over 50% in the past six months, though shares have declined recently to $1.72.

According to InvestingPro analysis, Expensify appears undervalued at current levels, with a Fair Value of $2.49. The company’s $170 million market cap reflects ongoing volatility, as highlighted in InvestingPro Tips.

On November 12, 2026, Mr. McLaughlin disposed of 237,139 shares directly. The weighted average price for these shares was $1.838, with individual sale prices ranging from $1.75 to $1.88. The following day, November 13, 2026, he sold an additional 123,075 shares directly. These shares were sold at a weighted average price of $1.826, with actual prices ranging from $1.785 to $1.865.

Following these transactions, Mr. McLaughlin beneficially owns 11,285,631 shares indirectly through the Steven J. McLaughlin Revocable Trust, for which he serves as the sole trustee. He also indirectly holds 1,783,610 shares through EXP 2020 SPV LP, where SF Roofdeck GP LLC acts as the general partner and is wholly owned by the Trust. Mr. McLaughlin disclaims beneficial ownership of these securities except to the extent of his pecuniary interest.

In other recent news, Expensify reported financial results for the third quarter of 2026, revealing a wider-than-expected loss. The company posted a loss of 4 cents per share, contrary to analysts’ projections of a 2-cent profit. Revenue for the quarter was $33 million, falling short of the anticipated $33.73 million. These results indicate that both earnings and revenue were below Wall Street forecasts. Despite improvements in adjusted results and cash flow, the company did not meet expectations. The financial shortfall highlights challenges Expensify faces in aligning with market predictions. The company’s performance will be closely watched by investors and analysts in the coming quarters.

Risks

  • Insider selling by a director and 10% owner could be perceived negatively by the market, potentially pressuring the stock price in the near term.
  • The company’s wider-than-expected Q3 2026 loss and revenue shortfall raise concerns about its ability to meet future earnings estimates, which could affect investor confidence.
  • The stock’s recent decline to $1.72 and ongoing volatility, as highlighted by InvestingPro, present uncertainty for shareholders.

More from Insider Trading

Kinetik Insider Sale: ISQ Global Fund Offloads $4.25 Million in Stock Nov 16, 2026 Saba Capital Adds $795K to BNY Mellon Strategic Municipals Stake Nov 16, 2026 Halozyme CEO Helen Torley Offloads $6 Million in Stock Under Pre-Set Trading Plan Nov 16, 2026 CorMedix CEO Joseph Todisco Purchases $391,200 in Company Shares Nov 16, 2026 Hinge Health Co-Founder Mecklenburg Offloads $24.48M in Shares Near 52-Week High Nov 16, 2026